These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 14678195)
21. Prevention of oral tolerance induction to ovalbumin and enhanced antigen presentation during a graft-versus-host reaction in mice. Strobel S; Mowat AM; Ferguson A Immunology; 1985 Sep; 56(1):57-64. PubMed ID: 4043996 [TBL] [Abstract][Full Text] [Related]
22. Anti-gamma delta T cell antibody blocks the induction and maintenance of oral tolerance to ovalbumin in mice. Mengel J; Cardillo F; Aroeira LS; Williams O; Russo M; Vaz NM Immunol Lett; 1995 Dec; 48(2):97-102. PubMed ID: 8719106 [TBL] [Abstract][Full Text] [Related]
23. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance. Chung Y; Lee SH; Kim DH; Kang CY J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078 [TBL] [Abstract][Full Text] [Related]
24. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production. Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748 [TBL] [Abstract][Full Text] [Related]
25. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70. Nieland JD; Kruisbeek AM Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081 [TBL] [Abstract][Full Text] [Related]
26. Deletion, but not anergy, is involved in TGF-beta-treated antigen-presenting cell-induced tolerance. Alard P; Clark SL; Kosiewicz MM Int Immunol; 2003 Aug; 15(8):945-53. PubMed ID: 12882832 [TBL] [Abstract][Full Text] [Related]
27. Control of CD4 T cell fate by antigen re-stimulation with or without CTLA-4 engagement 24 h after priming. Nakata Y; Uzawa A; Suzuki G Int Immunol; 2000 Apr; 12(4):459-66. PubMed ID: 10744647 [TBL] [Abstract][Full Text] [Related]
28. CTLA-4 is required for the induction of high dose oral tolerance. Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605 [TBL] [Abstract][Full Text] [Related]
29. Circumventing tolerance at the T cell or the antigen-presenting cell surface: antibodies that ligate CD40 and OX40 have different effects. Hochweller K; Sweenie CH; Anderton SM Eur J Immunol; 2006 Feb; 36(2):389-96. PubMed ID: 16402409 [TBL] [Abstract][Full Text] [Related]
30. Suppressor T cells, antigen-presenting cells and the role of I-J restriction in oral tolerance to ovalbumin. Mowat AM; Lamont AG; Parrott DM Immunology; 1988 May; 64(1):141-5. PubMed ID: 2968305 [TBL] [Abstract][Full Text] [Related]
31. Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies. Li F; Ravetch JV Science; 2011 Aug; 333(6045):1030-4. PubMed ID: 21852502 [TBL] [Abstract][Full Text] [Related]
32. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells. Croft M; Joseph SB; Miner KT J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124 [TBL] [Abstract][Full Text] [Related]
33. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis. Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023 [TBL] [Abstract][Full Text] [Related]
34. CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo. Wang Z; Davies JD Int Immunopharmacol; 2007 Feb; 7(2):249-65. PubMed ID: 17178393 [TBL] [Abstract][Full Text] [Related]
35. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eagar TN; Karandikar NJ; Bluestone JA; Miller SD Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563 [TBL] [Abstract][Full Text] [Related]
36. Effective priming of cytotoxic T lymphocyte precursors by subcutaneous administration of peptide antigens in liposomes accompanied by anti-CD40 and anti-CTLA-4 antibodies. Ito D; Ogasawara K; Matsushita K; Morohashi T; Namba K; Matsuki N; Kitaichi N; Inuyama Y; Hosokawa M; Nakayama E; Iwabuchi K; Onoé K Immunobiology; 2000 Apr; 201(5):527-40. PubMed ID: 10834311 [TBL] [Abstract][Full Text] [Related]
37. Functional maturation of lamina propria dendritic cells by activation of NKT cells mediates the abrogation of oral tolerance. Chang JH; Lee JM; Youn HJ; Lee KA; Chung Y; Lee AY; Kweon MN; Kim HY; Taniguchi M; Kang CY Eur J Immunol; 2008 Oct; 38(10):2727-39. PubMed ID: 18825753 [TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation. Mejri N; Gottstein B Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309 [TBL] [Abstract][Full Text] [Related]
39. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Ferlin WG; von der Weid T; Cottrez F; Ferrick DA; Coffman RL; Howard MC Eur J Immunol; 1998 Feb; 28(2):525-31. PubMed ID: 9521062 [TBL] [Abstract][Full Text] [Related]
40. CD40, CD80, and CD86 costimulatory molecules are differentially expressed on murine splenic antigen-presenting cells during the pre-implantation period of pregnancy, and they modulate regulatory T-cell abundance, peripheral cytokine response, and pregnancy outcome. Slawek A; Maj T; Chelmonska-Soyta A Am J Reprod Immunol; 2013 Aug; 70(2):116-26. PubMed ID: 23445188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]